These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28730788)

  • 21. DNA topoisomerase I and IIalpha expression in penile carcinomas: assessing potential tumour chemosensitivity.
    Berney DM; Stankiewicz E; Adlan AM; Kudahetti S; Biedrzycki OJ; Hadway P; Watkin N; Corbishley C
    BJU Int; 2008 Sep; 102(8):1040-4. PubMed ID: 18489530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topoisomerase I protein expression in primary colorectal cancer and recurrences after 5-FU-based adjuvant chemotherapy.
    Gouveris P; Lazaris AC; Papathomas TG; Nonni A; Kyriakou V; Delladetsima J; Patsouris ES; Tsavaris N
    J Cancer Res Clin Oncol; 2007 Dec; 133(12):1011-5. PubMed ID: 17605046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon.
    Staley BE; Samowitz WS; Bronstein IB; Holden JA
    Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa.
    Hirata S; Katoh O; Oguri T; Watanabe H; Yajin K
    Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topoisomerase I as a target of erlotinib and gefitinib: efficacy of combined treatments with camptothecin.
    Peleg R; Bobilev D; Priel E
    Int J Oncol; 2014 Mar; 44(3):934-42. PubMed ID: 24399039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CPT-11 may provide therapeutic efficacy for esophageal squamous cell cancer and the effects correlate with the level of DNA topoisomerase I protein.
    Nakajima Y; Miyake S; Nagai K; Kawano T; Iwai T
    Jpn J Cancer Res; 2001 Dec; 92(12):1335-41. PubMed ID: 11749700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.
    Hammond LA; Eckardt JR; Ganapathi R; Burris HA; Rodriguez GA; Eckhardt SG; Rothenberg ML; Weiss GR; Kuhn JG; Hodges S; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 1998 Jun; 4(6):1459-67. PubMed ID: 9626463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caspase complex in laryngeal squamous cell carcinoma.
    Chrysovergis A; S Papanikolaou V; Tsiambas E; Kikidis D; Maragoudakis P; Ragos V; Kyrodimos E
    J BUON; 2019; 24(1):1-4. PubMed ID: 30941944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topo IIα gene alterations correlated with survival in patients with diffuse large B-cell lymphoma.
    Chen Z; Wang J; Zhang H; Liu D; Li Y; Xu Y; Tan D; Chen D; Zhao X; Wang G
    Eur J Clin Invest; 2012 Mar; 42(3):310-20. PubMed ID: 21880040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
    Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical staining for DNA topoisomerase IIa in Hodgkin's disease.
    Brown MS; Holden JA; Rahn MP; Perkins SL
    Am J Clin Pathol; 1998 Jan; 109(1):39-44. PubMed ID: 9426516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
    Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
    Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity.
    McLeod HL; Keith WN
    Br J Cancer; 1996 Aug; 74(4):508-12. PubMed ID: 8761363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis.
    Tsiambas E; Ragos V; Georgakopoulos G; Rigopoulos DN; Fotiades PP; Chatziioannidis A; Stamatelopoulos A; Vilaras G; Karameris A
    J BUON; 2016; 21(2):450-5. PubMed ID: 27273957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical study of DNA topoisomerase I, p53, and Ki-67 in uterine carcinosarcomas.
    Lee SJ; Kim HS; Kim HS; Chun YK; Hong SR; Lee JH
    Hum Pathol; 2007 Aug; 38(8):1226-31. PubMed ID: 17490723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice.
    Kim R; Hirabayashi N; Nishiyama M; Jinushi K; Toge T; Okada K
    Int J Cancer; 1992 Mar; 50(5):760-6. PubMed ID: 1312063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of topoisomerase I in differentiating human intestinal epithelial cells.
    Ulukan H; Muller MT; Swaan PW
    Int J Cancer; 2001 Oct; 94(2):200-7. PubMed ID: 11668498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors.
    van der Zee AG; de Jong S; Keith WN; Hollema H; Boonstra H; de Vries EG
    Cancer Res; 1994 Feb; 54(3):749-55. PubMed ID: 8306337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.